YC-1 Stimulates the Expression of Gaseous Monoxide-Generating Enzymes in Vascular Smooth Muscle Cells
Authors:
- Kelly J. PeytonKPKelly J. Peyton
- Natalia N. MendelevNMNatalia N. Mendelev
- Hong WangHWHong Wang
- David A. TulisDTDavid A. Tulis
- William DuranteWDWilliam Durante
- 1 January 2009
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 75 (1) , 208-217
Abstract
The benzylindazole derivative 3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1) is an allosteric stimulator of soluble guanylate cyclase (sGC) that sensitizes the enzyme to the gaseous ligands carbon monoxide (CO) and nitric oxide (NO). In this study, we examined whether YC-1 also promotes the production of these gaseous monoxides by stimulating the expression of the inducible isoforms of heme oxygenase (HO-1) and NO synthase (iNOS) in vascular smooth muscle cells (SMCs). YC-1 increased HO-1 mRNA, protein, and promoter activity and potentiated cytokine-mediated expression of iNOS protein and NO synthesis by SMCs. The induction of HO-1 by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo[4,3-α]quinozalin-1-one (ODQ) or by the protein kinase G inhibitors (8R,9S,11S)-(-)-2-methyl-9-methoxyl-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo(a,g)cyclocta9(cde)trinen-1-one (KT 5823) and YGRKKRRQRRRPPLRKKKKKH-amide (DT-2) and was not duplicated by 8-bromo-cGMP or the NO-independent sGC stimulator 5-cyclopropyl-2[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b] pyridine-3-yl] pyrimidin-4-ylamine (BAY 41-2272). However, the YC-1-mediated induction of HO-1 was inhibited by the phosphatidylinositol-3-kinase (PI3K) inhibitors wortmannin and 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002). In contrast, the enhancement of cytokine-stimulated iNOS expression and NO production by YC-1 was prevented by ODQ and the protein kinase A inhibitor (9S,10S, 12R)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9, 12-epoxy-1H-diindolo(1,2,3-fg:3′,2′,1′-kl)pyrrolo(3,4-i)(1,6)-benzodiazocine-10-carboxylic acid hexyl ester (KT 5720) and was mimicked by 8-bromo-cGMP and BAY 41-2272. In conclusion, these studies demonstrate that YC-1 stimulates the expression of HO-1 and iNOS in vascular SMCs via the PI3K and sGC-cGMP-protein kinase A pathway, respectively. The ability of YC-1 to sensitize sGC to gaseous monoxides and simultaneously stimulate their production through the induction of HO-1 and iNOS provides a potent mechanism by which the cGMP-dependent and -independent biological actions of this agent are amplified.Keywords
This publication has 43 references indexed in Scilit:
- Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survivalCardiovascular Research, 2007
- YC‐1 attenuates LPS‐induced proinflammatory responses and activation of nuclear factor‐κB in microgliaBritish Journal of Pharmacology, 2007
- NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialNature Reviews Drug Discovery, 2006
- Role of carbon monxide in cardiovascular functionJournal of Cellular and Molecular Medicine, 2006
- A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse modelsThrombosis and Haemostasis, 2005
- CORM‐A1: a new pharmacologically active carbon monoxide‐releasing moleculeThe FASEB Journal, 2004
- YC-1-Mediated Vascular Protection through Inhibition of Smooth Muscle Cell Proliferation and Platelet FunctionBiochemical and Biophysical Research Communications, 2002
- Potentiation of carbon monoxide-induced relaxation of rat aorta by YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole]Canadian Journal of Physiology and Pharmacology, 2000
- Release of nitric oxide from endothelial cells stimulated by YC‐1, an activator of soluble guanylyl cyclaseBritish Journal of Pharmacology, 1999
- Atrial Natriuretic Peptide Enhances IL-1β-Stimulated Nitric Oxide Production in Cultured Rat Vascular Smooth Muscle CellsKidney and Blood Pressure Research, 1998